Philip Renaud

Managing Director at LB Advisors Ltd.

Philip Renaud

Philip Renaud

Managing Director at LB Advisors Ltd.

Overview
Career Highlights

Diagnos, Inc.

RelSci Relationships

177

Number of Boards

10

Relationships
RelSci Relationships are individuals Philip Renaud likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chairman of the Board & Chief Executive Officer at Goldstar Minerals, Inc.

Relationship likelihood: Strong

Founder at Stone Gold, Inc.

Relationship likelihood: Strong

Founder at Dundee Sarea LP

Relationship likelihood: Strong

Chief Executive Officer at Diagnos, Inc.

Relationship likelihood: Strong

President at ST Group, Inc.

Relationship likelihood: Strong

Director & Vice President at William G. Brissenden, Inc.

Relationship likelihood: Strong

Chief Operating Officer at Appian Capital Advisory LLP

Relationship likelihood: Strong

Director, President & Chief Executive Officer at Kane Biotech, Inc.

Relationship likelihood: Strong

Chairman, President & Chief Executive Officer at TrustPoint Innovation Technologies Ltd.

Relationship likelihood: Strong

Former Director, President & Chief Executive Officer at Kane Biotech, Inc.

Relationship likelihood: Strong

Paths to Philip Renaud
Potential Connections via
Relationship Science
You
Philip Renaud
Managing Director at LB Advisors Ltd.
Career History
Managing Director
1999 - Current
Managing Director
Current
Executive Chairman
2009 - 2015

Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis, which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care. The company was founded by Djamel Abdelkader Zighed in 1998 and is headquartered in Brossard, Canada.

Boards & Committees
Member, Advisory Board
Current

Dundee Sarea seeks investment opportunities in mid-market companies located in North America and Europe with revenues ranging from $50 to $400 million. The firm targets companies operating in the fields of manufacturing, distribution, industrial products, agriculture, energy and forestry. It provides equity financing for financial restructuring, recapitalizations, operational turnarounds, bankruptcy auctions & distressed sales, corporate divestitures or carve-outs, succession issues, and challenging sale processes with an investment size ranging from $15 to $50 million. It acquires controlling interests and also makes co-investments. It takes a seat on the board of directors.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Philip Renaud. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Philip Renaud's profile does not indicate a business or promotional relationship of any kind between RelSci and Philip Renaud.